0 Comments
0 Shares
1K Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Hematologic Malignancies Therapeutics Market: Advances in Targeted and Personalized TherapiesValued at USD 71.38 billion in 2024, the hematologic malignancies therapeutics market is projected to reach USD 76.63 billion in 2025 and USD 148.15 billion by 2034, growing at a CAGR of 7.6% during the forecast period 2025–2034. Leading companies include AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Johnson & Johnson, Novartis...0 Comments 0 Shares 87 Views 0 Reviews